Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 7;26(1):147.
doi: 10.1186/s13063-025-08851-5.

Impact of the aldehyde dehydrogenase 2 (ALDH2) gene testing on alcohol drinking behaviors among the Chinese Han population: study protocol of a single-center, open-label, randomized, controlled clinical trial

Dongli Lu #  1 , Yingneng Wen #  2 , Kaijun Liao  1 , Qiulian Lu  2 , Shiqin Wu  1 , Lin Fang  1 , Zhenghua Jiang  3 , Zhaochun Wu  4
Affiliations

Impact of the aldehyde dehydrogenase 2 (ALDH2) gene testing on alcohol drinking behaviors among the Chinese Han population: study protocol of a single-center, open-label, randomized, controlled clinical trial

Dongli Lu et al. Trials. .

Abstract

Background: Alcohol consumption may induce multiple disorders, and decreased alcohol consumption has been proved to be effective to reduce the incidence of alcohol-associated diseases and mortality. Pharmacotherapy is the most common option for the management of alcohol problems; however, it suffers from multiple problems. Non-pharmaceutical interventions are therefore of urgent need to change alcohol intake among alcohol users. Aldehyde dehydrogenase 2 (ALDH2), which encodes the ALDH2 gene, is an important enzyme in ethanol metabolism. Previous studies have demonstrated that individuals harboring ALDH2 gene mutations are more likely to present discomfort symptoms and are more susceptible to multiple cancers. It is hypothesized that ALDH2 gene testing may reduce alcohol consumption and the incidence of alcohol-associated disorders among unhealthy alcohol users.

Methods: A single-center, open-label, randomized, controlled clinical trial was designed, aiming to recruit 940 unhealthy alcohol users at ages of 18 to 60 years. All participants are randomized into the interventional and control groups, and both groups are given alcohol consumption health education. In addition, blood samples are collected from participants in the interventional group for ALDH2 gene testing, with testing reports issued, while ALDH2 gene testing is not performed in the control group. Changes in alcohol intake, hazardous drinking days, and alcohol-associated adverse events are recorded prior to and post-interventions. The primary outcome is alcohol intake, and the secondary outcomes are hazardous drinking days and alcohol-associated adverse events.

Discussion: This trial will provide strong evidence regarding the impact of ALDH2 gene testing on alcohol use behaviors.

Trial registration: The study has been registered in the Chinese Clinical Trial Registry (registration no. ChiCTR2400087726) on 2 August 2024.

Keywords: ALDH2 gene; Alcohol intake; Alcohol-related disease; Genetic testing.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate {24}: This single-center, open-label, randomized, controlled clinical trial has been approved by the Medical Ethics Review Committee of Nanping First Hospital Affiliated to Fujian Medical University (approval no. NPSY202309019) on September 27, 2023. Consent for publication {32}: Not applicable. Competing interests {28}: The authors declare no conflict of interests.

Figures

Fig. 1
Fig. 1
Flowchart of the trial
Fig. 2
Fig. 2
Schedule of enrollment, interventions, and assessments
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Edelman EJ, Fiellin DA. Alcohol Use. Ann Intern Med. 2016. 10.7326/L16-0107. - PubMed
    1. van den Brandt PA, Brandts L. Alcohol consumption in later life and reaching longevity: the Netherlands Cohort Study. Age Ageing. 2020. 10.1093/ageing/afaa003. - PMC - PubMed
    1. Abat C, Roussel Y, Chaudet H, et al. Alcohol and the global burden of disease. Lancet. 2019. 10.1016/S0140-6736(19)30713-5. - PubMed
    1. Rehm J, Rovira P, Llamosas-Falcón L, et al. Dose-response relationships between levels of alcohol use and risks of mortality or disease, for all people, by age, sex, and specific risk factors. Nutrients. 2021. 10.3390/nu13082652. - PMC - PubMed
    1. Skinner MD, Lahmek P, Pham H, et al. Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis. PLoS ONE. 2014. 10.1371/journal.pone.0087366. - PMC - PubMed

Publication types

Substances

Supplementary concepts

LinkOut - more resources